Supernus Pharmaceuticals shares owned by Ingalls & Snyder
Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Ingalls & Snyder
from 13F filings
Historical chart of Ingalls & Snyder investment in Supernus Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Supernus Pharmaceuticals held by Ingalls & Snyder consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Supernus Pharmaceuticals by Ingalls & Snyder
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $657k | 23k | 28.96 |
2023-09-30 | $681k | 25k | 27.58 |
2023-06-30 | $1.1M | 36k | 30.07 |
2023-03-31 | $1.3M | 36k | 36.23 |
2022-12-31 | $1.4M | 40k | 35.68 |
2022-09-30 | $1.4M | 40k | 33.84 |
2022-06-30 | $1.2M | 40k | 28.91 |
2022-03-31 | $1.3M | 40k | 32.32 |
2021-12-31 | $1.2M | 40k | 29.16 |
2021-09-30 | $1.9M | 70k | 26.68 |
2021-06-30 | $2.2M | 72k | 30.79 |
2021-03-31 | $1.9M | 72k | 26.17 |
2020-12-31 | $1.8M | 72k | 25.16 |
2020-09-30 | $1.5M | 71k | 20.84 |
2020-06-30 | $1.7M | 71k | 23.75 |
2020-03-31 | $1.3M | 71k | 17.99 |
2019-12-31 | $1.7M | 71k | 23.72 |
2019-09-30 | $4.8M | 175k | 27.48 |
2019-06-30 | $5.5M | 165k | 33.09 |
2019-03-31 | $6.0M | 171k | 35.04 |
2018-12-31 | $5.7M | 171k | 33.22 |
2018-09-30 | $8.6M | 171k | 50.35 |
2018-06-30 | $10M | 171k | 59.85 |
2018-03-31 | $7.9M | 174k | 45.80 |
2017-12-31 | $7.0M | 176k | 39.85 |
2017-09-30 | $7.0M | 176k | 40.00 |
2017-06-30 | $7.6M | 176k | 43.10 |
2017-03-31 | $5.7M | 181k | 31.30 |
2016-12-31 | $4.8M | 191k | 25.25 |
2016-09-30 | $4.8M | 193k | 24.73 |
2016-06-30 | $3.9M | 193k | 20.37 |